Company profile
Royalty Pharma plc Insider Trading
RPRXEvery SEC Form 4 insider trading filing for Royalty Pharma plc (RPRX) since April 2023 — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?
- Exchange
- Nasdaq
- Sector
- Pharmaceutical Preparations
- CIK
- 0001802768
- Filings
- 153
- Insiders
- 18
- Last filing
- 2026-08-19
Activity summary
Recent insider activity is bullish. Over the last 30 days, 4 insiders purchased shares. Buying was led by Hite Christopher.
Three year balance
Buy and sell value by quarter, Q4 23 to Q3 26. Royalty Pharma plc insiders are net sellers across the period shown.
Bars below the rule are sales, above are purchases. Largest quarter on the chart is $30.3M.
90 day insight
Over the last 90 days, Royalty Pharma plc insiders bought $37K across 13 transactions with no open-market sales.
- Most active insider: Hite Christopher with 9 transactions totaling $21.5M.
- Largest single sale: $6.4M by Hite Christopher on Jun 23, 2026.
- 100% of recent sales were pre-scheduled 10b5-1 trades — typically less informative than open-market activity.
Activity skews bullish — buys outpace sales.
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 19, 2026 | Hite Christopher | RPRX | Gift | 16,800 | — | — |
| Aug 18, 2026 | Hite Christopher | RPRX | Sale10b5 | 100,000 | $59.97 | $6.00M |
| Aug 13, 2026 | Coyne Terrance P. | RPRX | Sale10b5 | 1,772 | $59.14 | $105K |
| Aug 13, 2026 | Coyne Terrance P. | RPRX | Sale10b5 | 9,230 | $58.59 | $541K |
| Aug 7, 2026 | Coyne Terrance P. | RPRX | Gift | 18,500 | — | — |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Query this yourself
The same rows, over the API.
curl "https://api.form4api.com/v1/transactions?ticker=RPRX" \
-H "X-Api-Key: $KEY"Top insiders
By total value filed.